LEXINGTON, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative ...
-- Agreement provides Translate Bio with customized and dedicated manufacturing space for cGMP mRNA production for current and future programs -- LEXINGTON, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- ...
The USPTO has issued Translate Bio (TBIO) U.S. Patent 10,238,754, titled “Lipid Nanoparticle Compositions and Methods for mRNA Delivery.” This patent provides coverage for lipid-nanoparticle delivery ...
LOS ANGELES--(BUSINESS WIRE)--Inman, a frontrunner in real estate and technology news, has unveiled the distinguished lineup of recipients for the 2023 Best of Proptech Awards. Thomas Ma, Founder of ...
LEXINGTON, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative ...